Literature DB >> 6297884

Binding of fibronectin to the surface of group A, C, and G streptococci isolated from human infections.

L M Switalski, A Ljungh, C Rydén, K Rubin, M Höök, T Wadström.   

Abstract

Sixty-nine haemolytic and non-haemolytic streptococcal strains were isolated from various human infections and serogrouped with the coagglutination test. The amount of 125I-fibronectin bound to bacterial cells in a standard assay was determined. Most of the group A, C, and G strains were able to bind fibronectin. None of the group B or D strains bound significant amounts of fibronectin. Group A, C, and G streptococci appear to preferentially bind the N-terminal region of the fibronectin molecule because the 25K N-terminal fragment of the protein could effectively inhibit the binding of 125I-fibronectin to cells. Furthermore, the ability of representative strains of group A, C, and G to bind fibronectin was markedly reduced after trypsin treatment of the cells. Fibronectin binding components released from one strain by trypsin treatment inhibited the binding of 125I-fibronectin to all group A, C, and G streptococci strains. These findings indicate similarities among fibronectin binding proteins of the three groups of streptococci tested. However, the relative susceptibility to trypsin of fibronectin receptors of the three strains differed as did the relative potency of the inhibitory activity of receptors solubilized from different strains. Binding of fibronectin to the cell surface of group A, C, and G streptococci may contribute to virulence, for instance by promoting specific attachment to exposed fibronectin in open wounds and tissue lesions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6297884     DOI: 10.1007/bf02019939

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  20 in total

1.  Epidemic of pharyngitis due to streptococci of Lancefield group G.

Authors:  H R Hill; G G Caldwell; E Wilson; D Hager; R A Zimmerman
Journal:  Lancet       Date:  1969-08-16       Impact factor: 79.321

Review 2.  Summary of the workshop on perinatal infections due to group B Streptococcus.

Authors: 
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

3.  The adherence of group A streptococci to oropharyngeal cells: the lipoteichoic acid adhesin and fibronectin receptor.

Authors:  E H Beachey; W A Simpson
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 4.  Fibronectin: current concepts of its structure and functions.

Authors:  E Ruoslahti; E Engvall; E G Hayman
Journal:  Coll Relat Res       Date:  1981

5.  Fibronectin.

Authors:  D F Mosher
Journal:  Prog Hemost Thromb       Date:  1980

6.  Distribution of hemolytic streptococci in respiratory specimens.

Authors:  C B Forrer; P D Ellner
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

7.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

8.  Cryoprecipitate reversal of opsonic alpha2-surface binding glycoprotein deficiency in septic surgical and trauma patients.

Authors:  T M Saba; F A Blumenstock; W A Scovill; H Bernard
Journal:  Science       Date:  1978-08-18       Impact factor: 47.728

9.  beta 2-Microglobulin is bound to streptococcal M protein.

Authors:  L Björck; S K Tylewska; T Wadström; G Kronvall
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

Review 10.  Changes and changing concepts in the biology of group A streptococci and in the epidemiology of streptococcal infections.

Authors:  L W Wannamaker
Journal:  Rev Infect Dis       Date:  1979 Nov-Dec
View more
  31 in total

1.  Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.

Authors:  C Signäs; G Raucci; K Jönsson; P E Lindgren; G M Anantharamaiah; M Höök; M Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Identification of a fibronectin-binding protein (GfbA) in pathogenic group G streptococci.

Authors:  J B Kline; S Xu; A L Bisno; C M Collins
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.

Authors:  G S Chhatwal; K T Preissner; G Müller-Berghaus; H Blobel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

4.  Ultrastructural localization of the fibrinogen-binding domain of streptococcal M protein.

Authors:  M Rýc; E H Beachey; E Whitnack
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

5.  Interactions of fibronectin with Treponema pallidum.

Authors:  T J Fitzgerald; L A Repesh
Journal:  Genitourin Med       Date:  1985-06

6.  Guanidine extraction enhances the binding of human fibrinogen to group-B streptococci.

Authors:  G S Chhatwal; C Lämmler; H Blobel
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

7.  An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E. faecium growth.

Authors:  Fang Teng; Magdalena Kawalec; George M Weinstock; Waleria Hryniewicz; Barbara E Murray
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Specific attachment of Staphylococcus aureus to immobilized fibronectin.

Authors:  I Maxe; C Rydén; T Wadström; K Rubin
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

9.  Binding of Streptococcus pyogenes to soluble and insoluble fibronectin.

Authors:  H S Courtney; I Ofek; W A Simpson; D L Hasty; E H Beachey
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

10.  Variations in the binding of mammalian fibrinogens to streptococci of different animal origin.

Authors:  C Lämmler; G S Chhatwal; H Blobel
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.